CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients
- Status
- COMPLETED
- Phase
- NA
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
- Status
- RECRUITING
- Phase
- N/A
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of INCB086550 in Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
OH2 Injection in Combination With HX008 for Melanoma.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
War on Melanoma™ Public Health & Education Campaign
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
- Status
- RECRUITING
- Phase
- NA
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure Enables to Diminish Local Complications After Lymph Node Dissection in Patients With Metastatic Skin Tumors
- Status
- UNKNOWN
- Phase
- N/A
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1